2022年11月21日

加利福尼亞州艾利索VIEJO, 2022年11月21日/美通社/——Vertos Medical Inc.是腰椎管狹窄症(LSS)創新微創治療開發的領導者，今天宣布任命Mehrzad Khakpour博士為研發副總裁。Khakpour博士將負責指導公司研發的各個方麵。Mehrzad Khakpour, Vertos Medical Inc.研發副總裁。Khakpour博士為他在Vertos的角色帶來了豐富的技術創新和產品開發經驗，以及從成立到IPO的廣泛醫療設備經驗。他最近任職Sonendo Inc.(一家醫療技術公司，專注於通過行業首創的牙科創新拯救牙齒免於蛀牙)，在過去的14年裏，他負責產品組合和路線圖的開發和管理。他持有Sharif University of Technology的機械工程學士學位、the University of Minnesota的機械工程碩士學位以及the University of California, Riverside的機械工程博士學位。此外，他將很快完成西北大學凱洛格高管教育的首席產品官課程。Vertos Medical總裁兼首席執行官Eric wicems表示:“Mehrzad在Vertos團隊成長和轉型的關鍵時刻加入，因為我們將繼續發展溫和的®手術，並希望為背痛患者提供更多的治療選擇。”“Mehrzad在建立和管理以結果為導向、創新和敏捷的研發團隊方麵擁有豐富的經驗，這使他成為我們組織的寶貴財富。”Mehrzad說:“我很高興能在這個顯著增長的時期加入Vertos團隊。 "The Company's relentless pursuit to improve patients' quality of life requires a commitment to continual innovation that I am excited to be a part of moving forward. I am eager to develop a robust product pipeline that will provide additional therapies to treat patients suffering from low back pain." About Vertos Medical Inc. Vertos Medical is an interventional pain company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). mild®, its proprietary technology, is an image-guided outpatient procedure that removes a major root cause of lumbar spinal stenosis (LSS) through an incision smaller than the size of baby aspirin and doesn't require implants, general anesthesia, or stitches. The mild® Procedure has been clinically demonstrated to have safety outcomes similar to injections with durability out to 5 years, and patients typically return to activities of daily living within 24 hours with no restrictions. mild® is nationally covered by Medicare and has been performed on over 55,000 patients. Vertos Medical headquarters is located in Aliso Viejo, CA. To learn more and view clinical data, visit www.Vertosmed.com . SOURCE Vertos Medical Inc.